Freezing technique is effective alternative to lumpectomy

A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers according to Weill Cornell Medicine research.

Students blossom in extension summer internships

From using drones to track nutrient management in upstate corn fields to working with Head Start programs in Harlem, Cornell Cooperative Extension interns helped New York communities this summer.

Researchers develop way to ID diabetes patient-specific drugs

An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.

Tags on RNA silence X chromosome in females

New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.

Big data approach predicts drug toxicity in humans

A new data-driven approach developed by Weill Cornell Medicine scientists detects toxic side effects that may disqualify drugs from human use.

Johnson, Weill Cornell Medicine launch dual MBA/M.S.

Weill Cornell Medicine and Cornell's Samuel Curtis Johnson Graduate School of Management today announced a new dual MBA/M.S. degree program for health care leaders.

Patient looks to new ultrasound treatment to relieve tremors

MRI-guided ultrasound ablation, a new noninvasive treatment for tremors being offered at Weill Cornell Medicine, is helping people with essential tremors.

9/11 remembrance aims to 'build bridges of understanding'

Cornell will commemorate the 15th anniversary of the Sept. 11, 2001, terrorist attacks this Sunday, Sept. 11, at 6 p.m. on Ho Plaza in front of Willard Straight Hall. The ceremony is open to the public.

Grant launches Center on the Physics of Cancer Metabolism

Researchers from the College of Engineering and Weill Cornell Medicine will fight the spread of breast cancer and other cancers with a $9.3M, five-year grant from the National Cancer Institute.